XTX Topco’s ALX Oncology ALXO Stock Holding History

XTX Topco’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Buy	69,657 +25,516	+58%	+$45.7K	﹤0.01%	3400
2026 Q1	$88.5K	Buy	+44,141	New	+$84.1K	﹤0.01%	3141
2025 Q4	–	Sell	-26,621	Closed	-$48.7K	–	3282
2025 Q3	$48.7K	Sell	26,621 -48,149	-64%	-$41.7K	﹤0.01%	2177
2025 Q2	$31K	Sell	74,770 -17,489	-19%	-$8.83K	﹤0.01%	2102
2025 Q1	$57.5K	Sell	92,259 -171,597	-65%	-$206K	﹤0.01%	1980
2024 Q4	$441K	Sell	263,856 -53,466	-17%	-$82.2K	0.04%	882
2024 Q3	$578K	Buy	+317,322	New	+$1.18M	0.04%	720
2024 Q2	–	Sell	-10,911	Closed	-$122K	–	1825
2024 Q1	$122K	Buy	+10,911	New	+$153K	0.02%	1322
2023 Q4	–	Sell	-10,740	Closed	-$51.6K	–	1546
2023 Q3	$51.6K	Buy	+10,740	New	+$58.3K	0.01%	1274
2023 Q2	–	Sell	-25,817	Closed	-$117K	–	1381
2023 Q1	$117K	Buy	+25,817	New	+$196K	0.02%	1067

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

XTX Topco's ALXO Position: Q2 2026 in Review

XTX Topco increased its ALX Oncology (ALXO) stake by 58% in Q2 2026, buying an estimated $45.7K and bringing the position to 69,657 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

XTX Topco first reported a position in ALXO in Q1 2023 and has held it in 10 quarters since. The position peaked at $578K in Q3 2024. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

XTX Topco held 69,657 shares of ALX Oncology worth $144K as of Q2 2026.
XTX Topco bought 25,516 ALX Oncology shares in Q2 2026, an estimated $45.7K.
ALX Oncology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3400 holding.
XTX Topco first reported a position in ALX Oncology in Q1 2023 and has held it in 10 quarters since.
XTX Topco's ALX Oncology position peaked at $578K in Q3 2024.
93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.